[Congressional Record Volume 168, Number 186 (Thursday, December 1, 2022)]
[Senate]
[Page S6945]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 6504. Mr. KING (for Mr. McConnell) proposed an amendment to the 
bill H.R. 1193, to direct the Director of the National Institutes of 
Health, in consultation with the Director of the National Heart, Lung, 
and Blood Institute, to establish a program under which the Director of 
the National Institutes of Health shall support or conduct research on 
valvular heart disease, and for other purposes; as follows:

        Strike all after the enacting clause and insert the 
     following:

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``Cardiovascular Advances in 
     Research and Opportunities Legacy Act''.

     SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES.

       (a) In General.--The Secretary of Health and Human Services 
     (referred to in this section as the ``Secretary'') shall, as 
     appropriate, continue activities related to research, 
     education, and awareness of valvular heart diseases.
       (b) NIH Research Related to Valvular Heart Diseases.--
       (1) In general.--The Director of the National Institutes of 
     Health, in consultation with the Director of the National 
     Heart, Lung, and Blood Institute, may support or conduct 
     research regarding valvular heart diseases.
       (2) Support further research.--In order to improve 
     information on, and understanding of, causation and risk 
     factors for valvular heart diseases, research conducted or 
     supported under this subsection for such diseases may include 
     the following:
       (A) Use of advanced technological imaging and other 
     relevant methods to generate data related to valvular heart 
     diseases.
       (B) Assessing potential risk factors for sudden cardiac 
     arrest or sudden cardiac death from valvular heart diseases.
       (C) Other activities, as appropriate, in order to improve 
     the availability of information on, and advance research 
     related to, valvular heart diseases.
       (3) Mitral valve prolapse workshop.--Not later than 2 years 
     after the date of enactment of this Act, the Director of the 
     National Heart, Lung, and Blood Institute shall, as 
     appropriate, convene a workshop composed of subject matter 
     experts and stakeholders to identify research needs and 
     opportunities to develop recommendations for the 
     identification and treatment of individuals with mitral valve 
     prolapse, including such individuals who may be at risk for 
     sudden cardiac arrest or sudden cardiac death.
       (c) Prevention Activities to Improve Awareness of Sudden 
     Cardiac Death as a Result of Valvular Heart Diseases.--
       (1) In general.--The Secretary may carry out activities to 
     increase education and awareness of valvular heart diseases 
     in order to reduce the incidence of sudden cardiac death 
     caused by such diseases. The Secretary may--
       (A) award grants or contracts to public or nonprofit 
     private entities to carry out activities under this 
     subsection; and
       (B) directly, or through grants or contracts, provide 
     technical assistance with respect to such activities.
       (2) Certain activities.--Upon availability of applicable 
     data, projects carried out under paragraph (1) may include--
       (A) continuing activities at the Centers for Disease 
     Control and Prevention related to valvular heart diseases;
       (B) improving the awareness of the public concerning any 
     risk factors for, the symptoms of, and the public health 
     impact of, valvular heart diseases; and
       (C) enhancing public health data collection and improving 
     the quality of such data, as appropriate, regarding cardiac 
     arrests, including cardiac arrests that occur outside of the 
     hospital.
       (3) Grant prioritization.--The Secretary may, in awarding 
     grants or entering into contracts pursuant to paragraph (1), 
     give priority to entities seeking to carry out projects for 
     populations most impacted by valvular heart diseases.
       (4) Coordination of activities.--The Secretary shall, as 
     appropriate, ensure that activities under this section are 
     coordinated with other agencies and offices of the Department 
     of Health and Human Services that carry out activities 
     regarding valvular heart diseases.
       (5) Best practices.--The Secretary shall, as applicable and 
     appropriate, identify and disseminate best practices for 
     relevant health care providers related to valvular heart 
     diseases.
       (d) Authorization of Appropriations.--For purposes of 
     carrying out this section, there are authorized to be 
     appropriated $28,000,000 for each of fiscal years 2023 
     through 2027.

                          ____________________